Showing results (1931-1940 of 2,166) with videos related to
Sort By:
Pageof 217
Endocrinology|October 24, 2024
Characterization and Regulation of the Neonatal Growth Hormone SurgeDaniela O Gusmao, Ligia M M de Sousa, Maria E de Sousa, et al.ACS Nano|August 11, 2021
The Schottky-Mott Rule Expanded for Two-Dimensional Semiconductors: Influence of Substrate Dielectric ScreeningSoohyung Park, Thorsten Schultz, Dongguen Shin, et al.Nature Communications|November 6, 2022
Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonistFrancois Moreau, Nicholas S Kirk, Fa Zhang, et al.Oncotarget|September 30, 2015
TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromesKathy L McGraw, Thomas Cluzeau, David A Sallman, et al.Gigascience|May 3, 2023
TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factorsMarkus Hoffmann, Nico Trummer, Leon Schwartz, et al.Cancers|November 14, 2019
The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular CarcinomaTarek Kröhler, Sonja M Kessler, Kevan Hosseini, et al.Journal of Orthopaedic Trauma|September 30, 2025
The Impact of Reduction on Survivorship and Outcomes Following Locked Plate Fixation of Proximal Humerus FracturesTroy D Bornes, Craig E Klinger, Jeremy F Kubik, et al.Cancer Research|May 20, 2016
Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41Ashley A Basiorka, Kathy L McGraw, Leentje De Ceuninck, et al.Oncotarget|April 21, 2017
Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanomaStephanie Wittig-Blaich, Rainer Wittig, Steffen Schmidt, et al.Journal of Hematology & Oncology|March 7, 2012
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomideYuka Sugimoto, Mikkael A Sekeres, Hideki Makishima, et al.Pageof 217